According to proposals, reported in The Financial Times, some of the board’s non-executives will receive as much as £100,000 a year.
Some of the pharmaceutical giant’s investors have expressed concern at the plans fearing the rise could compromise the independence of non-executives.
Others however have said they understand the company’s position given the increased responsibility placed on non-executives in the recent tightening of corporate governance rules and the need to attract the best people in a global market.
Does Darwin's theory apply to taxation? Colin ponders...
The EC has been instructed to draft a European Union (EU) directive authorising an EU financial transaction tax, which would apply to ten of the EU’s 28 member states
Accountancy watchdog the FRC has dropped its investigation into the former chief financial officer of Tesco, nearly two years after the supermarket was engulfed in an accounting scandal
Colin imagines how Apple's logo might change in the wake of the EC's ruling over its Irish tax arrangements